232 related articles for article (PubMed ID: 34993609)
21. Texture analysis of FDG PET/CT for differentiating between FDG-avid benign and metastatic adrenal tumors: efficacy of combining SUV and texture parameters.
Nakajo M; Jinguji M; Nakajo M; Shinaji T; Nakabeppu Y; Fukukura Y; Yoshiura T
Abdom Radiol (NY); 2017 Dec; 42(12):2882-2889. PubMed ID: 28612161
[TBL] [Abstract][Full Text] [Related]
22. Differentiation of an adrenal mass in patients with non-small cell lung cancer by means of a normal range of adrenal standardized uptake values on FDG PET/CT.
Kim BS; Lee JD; Kang WJ
Ann Nucl Med; 2015 Apr; 29(3):276-83. PubMed ID: 25480483
[TBL] [Abstract][Full Text] [Related]
23. 18F-2-fluoro-2-deoxyglucose uptake in white adipose tissue on pediatric oncologic positron emission tomography (PET)/computed tomography (CT).
Wong KK; Sedig LK; Bloom DA; Hutchinson RJ; Shulkin BL
Pediatr Radiol; 2020 Apr; 50(4):524-533. PubMed ID: 31776602
[TBL] [Abstract][Full Text] [Related]
24. Accuracy of F-18 FDG PET/CT with optimal cut-offs of maximum standardized uptake value according to size for diagnosis of regional lymph node metastasis in patients with rectal cancer.
Bae SU; Won KS; Song BI; Jeong WK; Baek SK; Kim HW
Cancer Imaging; 2018 Sep; 18(1):32. PubMed ID: 30217167
[TBL] [Abstract][Full Text] [Related]
25. Determining the Diagnostic Value of 18F-Fluorodeoxyglucose Positron Emission/Computed Tomography in Detecting Prosthetic Aortic Graft Infection.
Mitra A; Pencharz D; Davis M; Wagner T
Ann Vasc Surg; 2018 Nov; 53():78-85. PubMed ID: 30012456
[TBL] [Abstract][Full Text] [Related]
26. What parameters from 18F-FDG PET/CT are useful in evaluation of adrenal lesions?
Kunikowska J; Matyskiel R; Toutounchi S; Grabowska-Derlatka L; Koperski L; Królicki L
Eur J Nucl Med Mol Imaging; 2014 Dec; 41(12):2273-80. PubMed ID: 25027709
[TBL] [Abstract][Full Text] [Related]
27. 18F-FDG PET/CT in the evaluation of adrenal masses in lung cancer patients.
Lu Y; Xie D; Huang W; Gong H; Yu J
Neoplasma; 2010; 57(2):129-34. PubMed ID: 20099976
[TBL] [Abstract][Full Text] [Related]
28. (18)F-FDG PET versus (18)F-FDG PET/CT for adrenal gland lesion characterization: a comparison of diagnostic efficacy in lung cancer patients.
Sung YM; Lee KS; Kim BT; Choi JY; Chung MJ; Shim YM; Yi CA; Kim TS
Korean J Radiol; 2008; 9(1):19-28. PubMed ID: 18253072
[TBL] [Abstract][Full Text] [Related]
29. Adrenal-to-liver SUV ratio is the best parameter for differentiation of adrenal metastases from adenomas using 18F-FDG PET/CT.
Watanabe H; Kanematsu M; Goshima S; Kondo H; Kawada H; Noda Y; Moriyama N
Ann Nucl Med; 2013 Aug; 27(7):648-53. PubMed ID: 23625579
[TBL] [Abstract][Full Text] [Related]
30. Prevalence and significance of thyroid uptake detected by ¹⁸F-FDG PET.
Ho TY; Liou MJ; Lin KJ; Yen TC
Endocrine; 2011 Oct; 40(2):297-302. PubMed ID: 21505891
[TBL] [Abstract][Full Text] [Related]
31.
Zhang X; Zhou J; Sun Y; Shi H; Ji Z; Jiang L
Clin Rheumatol; 2018 Jul; 37(7):1927-1935. PubMed ID: 29299706
[TBL] [Abstract][Full Text] [Related]
32. Role of
Dolci C; Ceppi L; Guerra L; Crivellaro C; Lamanna M; Adorni M; Elisei F; Bonazzi CM; Sina F; Fruscio R; Messa C
Int J Gynecol Cancer; 2019 Oct; 29(8):1298-1303. PubMed ID: 31366569
[TBL] [Abstract][Full Text] [Related]
33. Diagnostic and prognostic value of 18F-FDG PET/CT in comparison with morphological imaging in primary adrenal gland malignancies - a multicenter experience.
Cistaro A; Niccoli Asabella A; Coppolino P; Quartuccio N; Altini C; Cucinotta M; Alongi P; Balma M; Sanfilippo S; Buschiazzo A; Piccardo A; Fanelli M; Sambuceti G; Bomanji J; Baldari S; Bisi G; Fanti S; Rubini G
Hell J Nucl Med; 2015; 18(2):97-102. PubMed ID: 26187207
[TBL] [Abstract][Full Text] [Related]
34. The value of 18F-FDG PET-CT and 131I-norcholesterol scintigraphy in the characterization of high-risk adrenal masses.
Riaz S; Syed R; Aziz TA; Alnaim A; Chung TT; Wan S; Kurzawinski TR; Bomanji J
Nucl Med Commun; 2020 Mar; 41(3):189-195. PubMed ID: 31895761
[TBL] [Abstract][Full Text] [Related]
35. The value of adding (18)F-FDG PET/CT to adrenal protocol CT for characterizing adrenal metastasis (≥ 10 mm) in oncologic patients.
Park SY; Park BK; Kim CK
AJR Am J Roentgenol; 2014 Feb; 202(2):W153-60. PubMed ID: 24450697
[TBL] [Abstract][Full Text] [Related]
36. Prognostic implication of fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography in patients with recurrent papillary thyroid cancer.
Kang JH; Jung DW; Pak KJ; Kim IJ; Kim HJ; Cho JK; Shin SC; Wang SG; Lee BJ
Head Neck; 2018 Jan; 40(1):94-102. PubMed ID: 29130586
[TBL] [Abstract][Full Text] [Related]
37.
Cao L; Zhang D; Yang H; Xu W; Liu Y
World J Surg Oncol; 2023 Sep; 21(1):305. PubMed ID: 37749562
[TBL] [Abstract][Full Text] [Related]
38. The maximum standardized uptake value of metastatic site in 18 F-FDG PET/CT predicts molecular subtypes and survival in metastatic breast cancer: An Izmir Oncology Group study.
Cokmert S; Tanriverdi O; Karapolat I; Demir L; Bayoglu V; Can A; Akyol M; Yilmaz Y; Oktay Tarhan M
J BUON; 2016; 21(6):1410-1418. PubMed ID: 28039701
[TBL] [Abstract][Full Text] [Related]
39. FDG PET/CT in detection of adrenal metastasis in patients with renal cell carcinoma.
Kumar R; Shamim SA; Shandal V; Sharma P; Gadodia A; Malhotra A
Clin Nucl Med; 2011 Jul; 36(7):513-7. PubMed ID: 21637050
[TBL] [Abstract][Full Text] [Related]
40. Predictive Value of 18F-FDG PET/CT for Vascular Invasion in Patients With Hepatocellular Carcinoma Before Liver Transplantation.
Lin CY; Liao CW; Chu LY; Yen KY; Jeng LB; Hsu CN; Lin CL; Kao CH
Clin Nucl Med; 2017 Apr; 42(4):e183-e187. PubMed ID: 28114226
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
